Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Synergistic growth inhibition seen with BEZ-235 and dual EGFR and HER-2/neu inhibitor

Dec. 31, 2009

Activity of nab-rapamycin against breast cancer xenografts enhanced by other agents

Dec. 31, 2009

Tetrathiomolybdate may reduce endothelial progenitor cells in breast cancer patients

Dec. 30, 2009

MVA-BN-HER2 well tolerated, active in phase I breast cancer studies

Dec. 30, 2009

Breast cancer growth inhibition seen with JMR-132 and tamoxifen

Dec. 30, 2009

BTC induces apoptosis in PKCalpha overexpressing breast cancer cells

Dec. 30, 2009

New data indicate ridaforolimus-trastuzumab beneficial in refractory metastatic breast cancer

Dec. 30, 2009

BSI-201 added to gemcitabine/carboplatin improves survival in metastatic TNBC

Dec. 29, 2009

Interim study results suggest AE-37 vaccine may reduce breast cancer recurrence

Dec. 29, 2009

Ipsen discloses preliminary data from phase I trial of BN-83495 in breast cancer

Dec. 29, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...